Jane Street
ELOX

Jane Street’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Jane Street’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-463
Closed -$3K – 10745
2022
Q3 		$3K Buy
+463
New +$5.57K ﹤0.01% 9511
2022
Q2 		– Sell
-509
Closed -$11K – 11391
2022
Q1 		$11K Buy
+509
New +$10K ﹤0.01% 10064
2021
Q3 		– Sell
-265
Closed -$21K – 11084
2021
Q2 		$21K Buy
+265
New +$22.1K ﹤0.01% 9638

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Jane Street's ELOX Position: Q4 2022 in Review

Jane Street sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2022, closing a stake of 463 shares — an estimated $3K sold.

Jane Street first reported a position in ELOX in Q2 2021 and held it in 3 quarters. The position peaked at $21K in Q2 2021. 19 funds tracked by Wall St. Rank hold ELOX as of Q4 2022.

  • Jane Street reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Jane Street sold 463 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $3K.
  • Jane Street first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • Jane Street's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $21K in Q2 2021.
  • 19 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.